tradmap

BAX Financials Baxter International

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has declined 0.7% per year over the past 5 years.
  • Operating margin has contracted, at -2.7% in the latest year.
  • Free cash flow has declined 22.1% per year over the past 5 years.

Financial health

  • Total debt ($9.4B) exceeds cash ($2.0B); net debt is $7.5B.
  • Total debt has grown faster than revenue (8.7% vs -0.7% per year).
  • Operating income covered interest expense -1.1× in the latest year, down from 11× 5 years ago.
  • Total debt is 14× EBITDA.

Shareholder returns

  • Dividends have been paid for 15 consecutive years, consuming 104.8% of free cash flow.
  • The dividend has declined 6.0% per year over the past 5 years.
Revenue & net income
-$2B $5B $12B $0 2011 2013 2015 2017 2019 2021 2023 2025
RevenueNet income
Margins (gross / operating / net)
-28% 10% 49% 0% 2011 2013 2015 2017 2019 2021 2023 2025
GrossOperatingNet
Free cash flow (CFO − capex)
$0 $1B $2B 2011 2013 2015 2017 2019 2021 2023 2025
Free cash flow
Cash vs total debt
$0 $9B $18B 2011 2013 2015 2017 2019 2021 2023 2025
CashTotal debt
Cash flow: operating / investing / financing
-$11B -$1B $8B $0 2011 2013 2015 2017 2019 2021 2023 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MFCFTotal debtCash
2025 $11.2B -$957M 30.1% -2.7% $332M $9.4B $2.0B
2024 $10.6B -$649M 37.5% 0.1% $573M $15.3B $1.8B
2023 $10.4B $2.7B 40.1% 6.8% $1.3B $13.9B $3.1B
2022 $10.1B -$2.4B 35.3% -28.3% $834M $17.0B $1.6B
2021 $12.1B $1.3B 38.9% 11.1% $1.5B $18.1B $3.0B
2020 $11.7B $1.1B 39.3% 13.8% $1.2B $6.2B $3.7B
2019 $11.4B $1.0B 41.9% 15.6% $1.4B $3.3B
2018 $11.1B $1.5B 42.9% 14.3% $1.4B $1.8B
2017 $10.6B $602M 42.3% 12.2% $1.1B $3.4B
2016 $10.2B $5.0B 40.5% 7.3% $935M $2.8B
2015 $968M $860M $2.2B
2014 $2.5B $2.3B $2.9B
2013 $2.0B $2.5B $2.7B
2012 $2.3B $1.9B $3.3B
2011 $2.2B $1.9B $2.9B

Valuation over time

How the market has priced BAX against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 4.2 8.3 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
P/E
Price / sales (P/S)
0.0 1.2 2.4 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
P/S
Dividend yield (%)
0.0 3.1 6.2 Mar '23 Aug '23 Jan '24 Jun '24 Nov '24 Apr '25 Sep '25 Feb '26
Dividend yield %

Frequently asked questions

Is BAX growing its revenue and profit?

Over the past 5 years, Baxter International's revenue has declined 0.7% per year. These are computed facts, not advice.

How much debt does BAX have?

As of FY2025, Baxter International reported $9.4B of total debt against $2.0B of cash; operating income covered interest expense -1.1×.

What is BAX's profit margin?

In FY2025, gross margin was 30.1%, operating margin -2.7%, and net margin -8.5%.

What is BAX's P/E ratio?

As of Jun '26, Baxter International traded at a price-to-earnings ratio of about 6.6× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S and dividend yield have moved with the share price. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.